IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Renol Polychem IPO is a Book Building listing on NSE EMERGE exchange, with an ipo size of ₹ 25.77 Cr. The company is based in Rajkot and caters to Chemical sector. Corporate Makers Capital , 360 ONE WAM are the merchant bankers of Renol Polychem IPO. It is a SME Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 20th December 2024.
Renol Polychem IPO posted revenues of ₹ 72.00 Cr. and PAT of ₹ 6.84 Cr. in FY26 on annualised basis.
Revenue:
₹ 72.00 Cr.
EBITDA Margin:
13.33
% 
Net Worth: ₹ 14.47 Cr.
Market Capitalisation:
₹ 83.41 Cr.
P/E:
12.18 times
P/BV: 2.07 times
EV/EBITDA: 9.22 times
Financial results of Renol Polychem IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | May-25 | FY25 | FY24 | FY23 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 25.86 | 23.40 | 15.94 | 10.27 | |
| Net Worth | 14.47 | 13.33 | 8.69 | 2.70 | |
| Total Debt | 5.18 | 6.95 | 2.57 | 5.35 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
12.00
72.00 |
62.29 | 6.44 | 41.66 | |
EBITDA
EBITDA on annualised basis |
1.60
9.60 |
7.39 | 2.25 | 1.32 | |
PAT
PAT on annualised basis |
1.14
6.84 |
4.99 | 1.53 | 0.72 | |
Renol Polychem IPO PAT Margin is 9.50 % , ROCE (Return on Capital Employed) is 11.38 % as per latest financial. The below table shows Renol Polychem IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | May-25 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| EBITDA Margin (%) | 13.33 | 11.86 | 34.94 | 3.17 |
| PAT Margin (%) | 9.50 | 8.01 | 23.76 | 1.73 |
| EPS (₹) | 2.08 | 9.10 | 2.79 | [●] |
| ROE (%) | 7.88 | 37.43 | 17.61 | 26.67 |
| ROCE (%) | 11.38 | 64.18 | 37.42 | 32.17 |
| ROA (%) | 4.41 | 21.32 | 9.60 | 7.01 |
| Debt to Equity | 0.36 | 0.52 | 0.30 | 1.98 |
The market Capitalisation of Renol Polychem IPO is ₹ 83.41 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Renol Polychem IPO prospectus highlights an Return on Equity (ROE) of 7.88 % , Return on Assets (ROA) of 4.41 %, and an EBITDA Margin of 13.33 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Renol Polychem IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Renol Polychem IPO is ₹ 83.41 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Renol Polychem IPO has a Price-to-Earnings (PE) ratio of 12.18 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Renol Polychem IPO reported revenue of ₹ 72.00 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Renol Polychem IPO provide insights into sales growth, market demand, and business scalability.
Renol Polychem recorded an EBITDA of ₹ 9.60 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Renol Polychem Profit After Tax (PAT) is ₹ 6.84 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 72.00 Cr.
EBITDA Margin:
13.33
%
Net Worth: ₹ 14.47 Cr.
Market Capitalisation:
83.41
P/E:
12.18 times
P/BV: 2.07 times
EV/EBITDA:
9.22
Renol Polychem operates in Chemical and . The Issue is listed on NSE EMERGE in Aug, 2025. Renol Polychem IPO size was 25.77 with Issue price of 105.00 .
Merchant Banker(s) of Renol Polychem IPO: Corporate Makers Capital Limited , 360 ONE WAM Limited
Renol Polychem IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Renol Polychem IPO listed at a listing price of against the offer price of 105.00.
The current market price of Renol Polychem is .
Why Us?
